Cargando…

A new class of antibacterials, the imidazopyrazinones, reveal structural transitions involved in DNA gyrase poisoning and mechanisms of resistance

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Germe, Thomas, Vörös, Judit, Jeannot, Frederic, Taillier, Thomas, Stavenger, Robert A, Bacqué, Eric, Maxwell, Anthony, Bax, Benjamin D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934632/ https://www.ncbi.nlm.nih.gov/pubmed/29596599 http://dx.doi.org/10.1093/nar/gky241

Ejemplares similares

A new class of antibacterials, the imidazopyrazinones, reveal structural transitions involved in DNA gyrase poisoning and mechanisms of resistance
por: Germe, Thomas, et al.
Publicado: (2018)

Potent DNA gyrase inhibitors bind asymmetrically to their target using symmetrical bifurcated halogen bonds
por: Kolarič, Anja, et al.
Publicado: (2021)

Fragments of the Bacterial Toxin Microcin B17 as Gyrase Poisons
por: Collin, Frédéric, et al.
Publicado: (2013)

Structural basis of DNA gyrase inhibition by antibacterial QPT-1, anticancer drug etoposide and moxifloxacin
por: Chan, Pan F., et al.
Publicado: (2015)

Single-nucleotide-resolution mapping of DNA gyrase cleavage sites across the Escherichia coli genome
por: Sutormin, Dmitry, et al.
Publicado: (2019)

Vibrio cholerae ParE2 Poisons DNA Gyrase via a Mechanism Distinct from Other Gyrase Inhibitors
por: Yuan, Jie, et al.
Publicado: (2010)

A caged imidazopyrazinone for selective bioluminescence detection of labile extracellular copper(ii)
por: O'Sullivan, Justin J., et al.
Publicado: (2022)

Correction: A caged imidazopyrazinone for selective bioluminescence detection of labile extracellular copper(ii)
por: O’Sullivan, Justin J., et al.
Publicado: (2022)

Engineered Luciferase Reporter from a Deep Sea Shrimp Utilizing a Novel Imidazopyrazinone Substrate
por: Hall, Mary P., et al.
Publicado: (2012)

DNA Topoisomerase Inhibitors: Trapping a DNA-Cleaving Machine in Motion
por: Bax, Benjamin D., et al.
Publicado: (2019)

Antibacterial small molecules targeting the conserved TOPRIM domain of DNA gyrase
por: Walker, Scott S., et al.
Publicado: (2017)

Exploiting bacterial DNA gyrase as a drug target: current state and perspectives
por: Collin, Frédéric, et al.
Publicado: (2011)

Corrigendum to “Clinical Characteristics of Visual Dysfunction in Carbon Monoxide Poisoning Patients”
por: Bi, Wei-Kang, et al.
Publicado: (2021)

Antibacterial Properties of PEKK for Orthopedic Applications [Corrigendum]
Publicado: (2021)

Antibacterial properties and toxicity from metallic nanomaterials [Corrigendum]
Publicado: (2018)

High-throughput assays for DNA gyrase and other topoisomerases
por: Maxwell, Anthony, et al.
Publicado: (2006)

Architecture of Microcin B17 Synthetase: An Octameric Protein Complex Converting a Ribosomally Synthesized Peptide into a DNA Gyrase Poison
por: Ghilarov, Dmitry, et al.
Publicado: (2019)

Corrigendum to “Cutaneous Plasmacytosis with Perineural Involvement”
por: Brezinski, Elizabeth A., et al.
Publicado: (2016)

A Series of Spiropyrimidinetriones that Enhances DNA Cleavage Mediated by Mycobacterium tuberculosis Gyrase
por: Byl, Jo Ann W., et al.
Publicado: (2023)

Tuning the Surface Coating of IONs Toward Efficient Sonochemical Tethering and Sustained Liberation of Topoisomerase II Poisons [Corrigendum]
Publicado: (2021)

Pentapeptide repeat protein QnrB1 requires ATP hydrolysis to rejuvenate poisoned gyrase complexes
por: Mazurek, Łukasz, et al.
Publicado: (2021)

Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains
por: Liu, Huayong, et al.
Publicado: (2015)

The role of monovalent cations in the ATPase reaction of DNA gyrase
por: Hearnshaw, Stephen James, et al.
Publicado: (2015)

The Naphthoquinone Diospyrin Is an Inhibitor of DNA Gyrase with a Novel Mechanism of Action
por: Karkare, Shantanu, et al.
Publicado: (2013)

Trends and Outcomes of Acute Poisoning in Felege Hiwot Comprehensive Specialized Hospital Medical Intensive Care Units: Retrospective Study [Corrigendum]
Publicado: (2023)

The role of Ca(2+) in the activity of Mycobacterium tuberculosis DNA gyrase
por: Karkare, Shantanu, et al.
Publicado: (2012)

Spiropyrimidinetriones: a Class of DNA Gyrase Inhibitors with Activity against Mycobacterium tuberculosis and without Cross-Resistance to Fluoroquinolones
por: Basarab, Gregory S., et al.
Publicado: (2022)

Corrigendum to “Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment”
por: Shazly, Gamal A.
Publicado: (2017)

Corrigendum to “Correction of a Class III Malocclusion with a Functional Shift and Severe Crowding”
por: Alogaibi, Yahya A., et al.
Publicado: (2021)

Synthesis, construction, and evaluation of self-assembled nano-bacitracin A as an efficient antibacterial agent in vitro and in vivo [Corrigendum]
Publicado: (2019)

Corrigendum to “Mycosynthesis of silver nanoparticles bearing antibacterial activity” [Saudi Pharm. J. 24 (2016) 140–146]
por: Azmath, Pasha, et al.
Publicado: (2017)

Synthesis, Construction, and Evaluation of Self-Assembled Nano-Bacitracin a as an Efficient Antibacterial Agent in vitro and in vivo [Corrigendum]
Publicado: (2020)

Corrigendum to “Antibacterial Properties of Aloe vera on Intracanal Medicaments against Enterococcus faecalis Biofilm at Different Stages of Development”
por: Ghasemi, Negin, et al.
Publicado: (2021)

DNA Gyrase Is the Target for the Quinolone Drug Ciprofloxacin in Arabidopsis thaliana
por: Evans-Roberts, Katherine M., et al.
Publicado: (2016)

Nanosilver/poly (DL-lactic-co-glycolic acid) on titanium implant surfaces for the enhancement of antibacterial properties and osteoinductivity [Corrigendum]
Publicado: (2019)

Antibacterial Evaluation and Virtual Screening of New Thiazolyl-Triazole Schiff Bases as Potential DNA-Gyrase Inhibitors
por: Nastasă, Cristina, et al.
Publicado: (2018)

Corrigendum to “Instructors' Perceptions of Mostly Seated Exercise Classes: Exploring the Concept of Chair Based Exercise”
por: Robinson, Katie R., et al.
Publicado: (2017)

Optimizing care transitions: the role of the community pharmacist [Corrigendum]
Publicado: (2019)

A monoclonal antibody that inhibits mycobacterial DNA gyrase by a novel mechanism
por: Manjunatha, Ujjini H., et al.
Publicado: (2005)

Insights into the antibacterial mechanism of PEGylated nano-bacitracin A against Streptococcus pneumonia: both penicillin-sensitive and penicillin-resistant strains [Corrigendum]
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_f8npk4e0fplgoddf9eup5qhqel